{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T19:35:42Z","timestamp":1795030542876,"version":"4.10.2"},"reference-count":49,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:sec>\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Treatments are needed to slow progression of or reduce incidence of myopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the efficacy and safety of daily 650-nm low-level red light (LLRL) for myopia treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>Single-masked, randomized clinical trial at 1 site in China. Baseline measurements were completed from August to September 2021. Participants were children aged 6 to 12 years with spherical equivalent error (SER) of \u22126 diopters (D) to 3 D. Data were analyzed from March to July 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Irradiation daily with 650-nm LLRL for 3 minutes twice daily 4 or more hours apart or no intervention.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary outcomes were changes in cycloplegia SER and axial length (AL) at 6- and 12-month follow-up visits. Safety was assessed on masked fundus photograph evaluations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 336 children were randomly allocated into the LLRL group or control group in a 1:1 ratio. The control group contained 86 female patients (51.2%), and the treatment group contained 90 female patients (53.6%). The mean (SD) age, SER, and AL were 9.0 (1.9) years, \u22121.3 (1.5) D, and 23.8 (1.0) mm for all patients. A total of 161 (95.8%) in the LLRL group and 159 (94.6%) in the control group returned for the 6-month follow-up. A total of 157 (93.5%) in the LLRL group and 152 (90.5%) in the control group returned for the 12-month follow-up. Mean (SD) changes in SER were 0.15 (0.16) D and \u22120.26 (0.21) D for the LLRL group and the control group, respectively (difference, \u22120.41 D; 95% CI, \u22120.48 to \u22120.34 D;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), at 6 months and 0.24 (0.27) D and \u22120.65 (0.33) D for the LLRL group and the control group, respectively (difference, \u22120.89 D; 95% CI, \u22120.95 to \u22120.83 D;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), at 12 months. Mean (SD) changes in AL were \u22120.06 (0.08) mm and 0.13 (0.12) mm for the LLRL group and control group, respectively (difference, 0.19 mm; 95% CI, 0.16 to 0.22 mm;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), at 6 months and \u22120.11 (0.10) mm and 0.26 (0.16) mm for the LLRL group and control group, respectively (difference, 0.37 mm; 95% CI, 0.34 to 0.40 mm;\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001). Masked fundus photograph review did not identify retinal changes in either group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions and relevance<\/jats:title>\n                    <jats:p>These findings suggest daily use of 650-nm LLRL for 1 year can slow progression of SER and AL without safety concerns identified. Confirmation of these findings at independent sites seems warranted, as well as determining whether these effects can be sustained with or without continued treatment and whether LLRL has any effect on pathological myopia.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.chictr.org.cn\/showproj.html?proj=166306\">ChiCTR2200058963<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.0801","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T11:36:12Z","timestamp":1714044972000},"page":"560","source":"Crossref","is-referenced-by-count":62,"title":["Daily Low-Level Red Light for Spherical Equivalent Error and Axial Length in Children With Myopia"],"prefix":"10.1001","volume":"142","author":[{"given":"Kai","family":"Cao","sequence":"first","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Tian","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Li","family":"Ma","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Qiang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Li","sequence":"additional","affiliation":[{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Bing","family":"Jin","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jie","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"},{"name":"Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"eoi240018r1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/j.ophtha.2021.11.023","article-title":"Effect of repeated low-level red-light therapy for myopia control in children: a multicenter randomized controlled trial.","volume":"129","author":"Jiang","year":"2022","journal-title":"Ophthalmology"},{"issue":"6","key":"eoi240018r2","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1007\/s40123-022-00585-w","article-title":"Investigation of the efficacy and safety of 650 nm low-level red light for myopia control in children: a randomized controlled trial.","volume":"11","author":"Tian","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"eoi240018r3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.ophtha.2022.10.002","article-title":"Longitudinal changes and predictive value of choroidal thickness for myopia control after repeated low-level red-light therapy.","volume":"130","author":"Xiong","year":"2023","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi240018r4","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/opo.v42.2","article-title":"Low-intensity, long-wavelength red light slows the progression of myopia in children: an Eastern China-based cohort.","volume":"42","author":"Zhou","year":"2022","journal-title":"Ophthalmic Physiol Opt"},{"issue":"2","key":"eoi240018r5","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ophtha.2022.08.024","article-title":"Myopia control effect of repeated low-level red-light therapy in Chinese children: a randomized, double-blind, controlled clinical trial.","volume":"130","author":"Dong","year":"2023","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi240018r6","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/ceo.v50.9","article-title":"Sustained and rebound effect of repeated low-level red-light therapy on myopia control: a 2-year post-trial follow-up study.","volume":"50","author":"Xiong","year":"2022","journal-title":"Clin Exp Ophthalmol"},{"issue":"4","key":"eoi240018r7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/opo.v42.4","article-title":"Manual and software-based measurements of treatment zone parameters and characteristics in children with slow and fast axial elongation in orthokeratology.","volume":"42","author":"Guo","year":"2022","journal-title":"Ophthalmic Physiol Opt"},{"issue":"12","key":"eoi240018r8","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1136\/bjophthalmol-2020-318708","article-title":"Association of polymorphisms in ZFHX1B, KCNQ5 and GJD2 with myopia progression and polygenic risk prediction in children.","volume":"105","author":"Chen","year":"2021","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"eoi240018r9","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1167\/iovs.63.1.8","article-title":"Annual incidences and progressions of myopia and high myopia in Chinese schoolchildren based on a 5-year cohort study.","volume":"63","author":"Li","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi240018r10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1097\/APO.0000000000000474","article-title":"Light intensity in nursery schools: a possible factor in refractive development.","volume":"11","author":"Cohen","year":"2022","journal-title":"Asia Pac J Ophthalmol (Phila)"},{"issue":"10","key":"eoi240018r11","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1007\/s10792-023-02762-7","article-title":"Six-month repeated irradiation of 650 nm low-level red light reduces the risk of myopia in children: a randomized controlled trial.","volume":"43","author":"Tian","year":"2023","journal-title":"Int Ophthalmol"},{"issue":"8","key":"eoi240018r12","first-page":"1069","article-title":"Two-year add-on effect of using low concentration atropine in poor responders of orthokeratology in myopic children.","volume":"106","author":"Chen","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"8","key":"eoi240018r13","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1167\/iovs.63.8.10","article-title":"Peripheral refraction with toric orthokeratology and soft toric multifocal contact lenses in myopic astigmatic eyes.","volume":"63","author":"Tomiyama","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi240018r14","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.ajo.2021.12.014","article-title":"The association of choroidal thickening by atropine with treatment effects for myopia: two-year clinical trial of the low-concentration atropine for myopia progression (LAMP) Study.","volume":"237","author":"Yam","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"eoi240018r15","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1007\/s40123-022-00572-1","article-title":"Efficacy and safety of consecutive use of 1% and 0.01% atropine for myopia control in Chinese children: the atropine for children and adolescent myopia progression study.","volume":"11","author":"Ye","year":"2022","journal-title":"Ophthalmol Ther"},{"issue":"3","key":"eoi240018r16","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/opo.v42.3","article-title":"The effect of peripheral defocus on axial growth and modulation of refractive error in hyperopes.","volume":"42","author":"Beasley","year":"2022","journal-title":"Ophthalmic Physiol Opt"},{"issue":"5","key":"eoi240018r17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1167\/iovs.61.5.53","article-title":"Defocus inc multiple segments spectacle lenses changed the relative peripheral refraction: a 2-year randomized clinical trial.","volume":"61","author":"Zhang","year":"2020","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"11","key":"eoi240018r18","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/jama.2015.10803","article-title":"Effect of time spent outdoors at school on the development of myopia among children in China: a randomized clinical trial.","volume":"314","author":"He","year":"2015","journal-title":"JAMA"},{"issue":"5","key":"eoi240018r19","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1001\/jamapediatrics.2019.0278","article-title":"Outdoor activity protects against childhood myopia-let the sun shine in.","volume":"173","author":"Zadnik","year":"2019","journal-title":"JAMA Pediatr"},{"issue":"4","key":"eoi240018r20","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ophtha.2015.11.010","article-title":"Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis.","volume":"123","author":"Huang","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi240018r21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ophtha.2011.07.031","article-title":"Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (atropine for the treatment of myopia 2).","volume":"119","author":"Chia","year":"2012","journal-title":"Ophthalmology"},{"issue":"11","key":"eoi240018r22","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1136\/bjophthalmol-2019-315440","article-title":"Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: low-dose atropine and myopia progression.","volume":"104","author":"Fu","year":"2020","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"eoi240018r23","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","article-title":"Safety and efficacy of low-dose atropine eyedrops for the treatment of myopia progression in Chinese children: a randomized cinical trial.","volume":"138","author":"Wei","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"8","key":"eoi240018r24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1001\/jamaophthalmol.2023.2855","article-title":"Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial.","volume":"141","author":"Repka","year":"2023","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"eoi240018r25","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1167\/tvst.11.10.33","article-title":"Efficacy comparison of repeated low-level red light and low-dose atropine for myopia control: a randomized controlled trial.","volume":"11","author":"Chen","year":"2022","journal-title":"Transl Vis Sci Technol"},{"issue":"3","key":"eoi240018r26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/pho.2011.3089","article-title":"Low-level laser therapy improves visual acuity in adolescent and adult patients with amblyopia.","volume":"30","author":"Ivandic","year":"2012","journal-title":"Photomed Laser Surg"},{"issue":"1","key":"eoi240018r27","first-page":"145","article-title":"Photobiomodulation for the treatment of retinal diseases: a review.","volume":"9","author":"Geneva","year":"2016","journal-title":"Int J Ophthalmol"},{"issue":"3","key":"eoi240018r28","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1097\/01.ICL.0000075011.87891.39","article-title":"Unusual morphology in orthokeratology contact lens-related cornea ulcer.","volume":"29","author":"Wang","year":"2003","journal-title":"Eye Contact Lens"},{"issue":"1","key":"eoi240018r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2021.101530","article-title":"Efficacy, predictability and safety of long-term orthokeratology: an 18-year follow-up study.","volume":"45","author":"Gispets","year":"2022","journal-title":"Cont Lens Anterior Eye"},{"issue":"1","key":"eoi240018r30","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1097\/ICL.0000000000000219","article-title":"The safety of orthokeratology\u2013a systematic review.","volume":"42","author":"Liu","year":"2016","journal-title":"Eye Contact Lens"},{"issue":"12","key":"eoi240018r31","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.ophtha.2008.06.034","article-title":"Safety of overnight orthokeratology for myopia: a report by the American Academy of Ophthalmology.","volume":"115","author":"Van Meter","year":"2008","journal-title":"Ophthalmology"},{"issue":"2","key":"eoi240018r32","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.63.2.34","article-title":"Choroidal thickness and its association with age, axial length, and refractive error in chinese adults.","volume":"63","author":"Xie","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"eoi240018r33","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.ajo.2012.07.015","article-title":"The relationship between axial length and choroidal thickness in eyes with high myopia.","volume":"155","author":"Flores-Moreno","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"eoi240018r34","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1167\/iovs.63.5.34","article-title":"Choroidal thickening during young adulthood and baseline choroidal thickness predicts refractive error change.","volume":"63","author":"Lee","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"eoi240018r35","doi-asserted-by":"publisher","first-page":"7578","DOI":"10.1167\/iovs.13-12772","article-title":"Choroidal thickness in myopic and nonmyopic children assessed with enhanced depth imaging optical coherence tomography.","volume":"54","author":"Read","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"eoi240018r36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1167\/tvst.8.4.9","article-title":"Weekly changes in axial length and choroidal thickness in children during and following orthokeratology treatment with different compression factors.","volume":"8","author":"Lau","year":"2019","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"eoi240018r37","first-page":"111","article-title":"Short-term refractive and ocular parameter changes after topical atropine.","volume":"10","author":"Ho","year":"2019","journal-title":"Taiwan J Ophthalmol"},{"issue":"12","key":"eoi240018r38","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1016\/j.ophtha.2006.05.062","article-title":"Atropine for the treatment of childhood myopia.","volume":"113","author":"Chua","year":"2006","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi240018r39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12886-022-02461-4","article-title":"Axial length shortening after orthokeratology and its relationship with myopic control.","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"eoi240018r40","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.ophtha.2012.07.048","article-title":"Subfoveal choroidal thickness: the Beijing Eye Study.","volume":"120","author":"Wei","year":"2013","journal-title":"Ophthalmology"},{"issue":"8","key":"eoi240018r41","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1167\/iovs.18-26397","article-title":"Changes in choroidal thickness and choroidal blood perfusion in guinea pig myopia.","volume":"60","author":"Zhang","year":"2019","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"eoi240018r42","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2020.108332","article-title":"PPAR? modulates refractive development and form deprivation myopia in guinea pigs.","volume":"202","author":"Pan","year":"2021","journal-title":"Exp Eye Res"},{"key":"eoi240018r43","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ajo.2020.01.003","article-title":"Changes in choroidal thickness varied by age and refraction in children and adolescents: a 1-year longitudinal study.","volume":"213","author":"Xiong","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"eoi240018r44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/opo.v40.5","article-title":"Topical bendazol inhibits experimental myopia progression and decreases the ocular accumulation of HIF-1a protein in young rabbits.","volume":"40","author":"Tong","year":"2020","journal-title":"Ophthalmic Physiol Opt"},{"issue":"30","key":"eoi240018r45","doi-asserted-by":"publisher","first-page":"E7091","DOI":"10.1073\/pnas.1721443115","article-title":"Scleral hypoxia is a target for myopia control.","volume":"115","author":"Wu","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"eoi240018r46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102878","article-title":"Scleral HIF-1a is a prominent regulatory candidate for genetic and environmental interactions in human myopia pathogenesis.","volume":"57","author":"Zhao","year":"2020","journal-title":"EBioMedicine"},{"issue":"6","key":"eoi240018r47","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1007\/s00431-023-04921-5","article-title":"Prevention of myopia shift and myopia onset using 0.01% atropine in premyopic children\u2014a prospective, randomized, double-masked, and crossover trial.","volume":"182","author":"Wang","year":"2023","journal-title":"Eur J Pediatr"},{"issue":"6","key":"eoi240018r48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1001\/jama.2022.24162","article-title":"Effect of low-concentration atropine eyedrops vs placebo on myopia incidence in children: the LAMP2 randomized clinical trial.","volume":"329","author":"Yam","year":"2023","journal-title":"JAMA"},{"issue":"4","key":"eoi240018r49","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.9612","article-title":"Effect of repeated low-level red light on myopia prevention among children in china with premyopia: a randomized clinical trial.","volume":"6","author":"He","year":"2023","journal-title":"JAMA Netw Open"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2817624\/jamaophthalmology_cao_2024_oi_240018_1718141460.87732.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T11:08:48Z","timestamp":1718881728000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2817624"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.0801","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}